Meli Pharm

Schaarbeek ·KBO/BCE: BE 0789.989.972

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	27-11-2025	119 d late	2025-00571510
31-12-2023	31-07-2024	26-10-2024	87 d late	2024-00515200
31-12-2022	31-07-2023	30-08-2023	30 d late	2023-00373950

Metric	This company	Sector median	Position in the sector
Solvency	71.3%	20.4%	better than 88% of 6698 sector peers
Net result	€14k	€4k	better than 68% of 6678 sector peers
Equity	€151k	€16k	better than 91% of 6712 sector peers
Gross operating margin	€23k	€24k	better than 49% of 6657 sector peers
Total assets	€212k	€94k	better than 72% of 6702 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€212k
Fixed assets	21/28	€29k
Tangible fixed assets	22/27	€29k
Current assets	29/58	€183k
Amounts receivable within one year	40/41	€162k
Cash & bank	54/58	€21k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€212k
Equity	10/15	€151k
Contributions / capital	10/11	€3k
Reserves	13	€22k
Accumulated profits (losses)	14	€127k
Amounts payable	17/49	€61k
Amounts payable after one year	17	€16k
Amounts payable within one year	42/48	€45k
Trade debts payable within one year	44	€2k
Income statement
Gross operating margin	9900	€23k
Operating result	9901	€13k
Financial income	75	€7k
Financial charges	65	€2k
Result before taxes	9903	€19k
Income taxes	67/77	€4k
Net result for the period	9904	€14k
Result to be appropriated	9905	€14k

Summary